THE NEW SURGERY — All Prescriptions & Medications — Page 3
Practice Code: C86034 | MEXBOROUGH, S64 0DB
Showing results 101-150 of 591
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hyoscine butylbromide | 434 | 30.0K | £2.2K | +86.2% ▲ |
| Umeclidinium bromide/vilanterol | 430 | 437 | £13.5K | +120.5% ▲ |
| Hydroxocobalamin | 427 | 556 | £1.2K | -11.3% ▼ |
| Hydroxychloroquine sulfate | 427 | 12.9K | £888 | +120.5% ▲ |
| Betamethasone valerate | 423 | 36.4K | £2.0K | +9.9% ▲ |
| Finasteride | 422 | 12.2K | £427 | -35.6% ▼ |
| Carbamazepine | 394 | 24.9K | £2.3K | +32.8% ▲ |
| Latanoprost | 382 | 5,128 | £1.8K | -21.3% ▼ |
| Insulin glargine | 381 | 1,906 | £15.9K | +34.2% ▲ |
| Sumatriptan succinate | 379 | 2,547 | £2.1K | +7.0% ▲ |
| Olanzapine | 363 | 8,995 | £955 | -2.0% ▼ |
| Other multivitamin preparations | 361 | 9,099 | £3.2K | +108.9% ▲ |
| Doxycycline hyclate | 359 | 4,058 | £386 | -30.0% ▼ |
| Insulin aspart | 353 | 2,549 | £15.6K | -7.3% ▼ |
| 351 | 708 | £25.1K | -35.6% ▼ | |
| Hydrocortisone | 337 | 8,845 | £1.4K | -24.8% ▼ |
| Famotidine | 326 | 10.6K | £6.0K | -33.2% ▼ |
| Linagliptin | 316 | 6,335 | £7.2K | -22.9% ▼ |
| Eplerenone | 310 | 6,613 | £816 | +16.9% ▲ |
| Oxybutynin | 308 | 10.8K | £2.7K | +61.7% ▲ |
| Nitrofurantoin | 307 | 4,366 | £3.4K | -35.7% ▼ |
| 296 | 356 | £1.9K | +25.3% ▲ | |
| Tadalafil | 295 | 5,005 | £2.3K | +73.5% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 294 | 298 | £13.2K | +75.8% ▲ |
| Pioglitazone hydrochloride | 293 | 6,174 | £285 | +231.3% ▲ |
| Methotrexate | 284 | 7,548 | £451 | -12.7% ▼ |
| Quetiapine | 275 | 10.8K | £6.3K | -55.8% ▼ |
| Prochlorperazine maleate | 275 | 9,600 | £677 | +36.1% ▲ |
| Fluticasone furoate/vilanterol | 274 | 276 | £6.2K | +77.0% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 270 | 29.7K | £1.8K | +19.5% ▲ |
| Mometasone furoate | 267 | 287 | £2.2K | -33.5% ▼ |
| Edoxaban | 263 | 6,461 | £10.7K | -62.5% ▼ |
| 261 | 44.1K | £2.7K | +157.0% ▲ | |
| Ropinirole hydrochloride | 257 | 6,821 | £3.5K | +141.9% ▲ |
| Irbesartan | 249 | 5,936 | £267 | +2.2% ▲ |
| Timolol and bimatoprost | 249 | 3,240 | £3.8K | +64.1% ▲ |
| Progesterone | 248 | 19.7K | £3.7K | -40.8% ▼ |
| Pramipexole | 241 | 11.0K | £2.1K | +145.5% ▲ |
| Mesalazine (Systemic) | 240 | 21.6K | £9.5K | +0.2% vs avg |
| Biphasic insulin aspart | 237 | 1,691 | £10.1K | +133.4% ▲ |
| Umeclidinium bromide | 236 | 236 | £6.2K | +282.8% ▲ |
| Glyceryl trinitrate | 234 | 929 | £571 | -1.1% vs avg |
| 234 | 2,105 | £477 | +12.0% ▲ | |
| Tiotropium bromide | 233 | 3,197 | £5.8K | -23.4% ▼ |
| Rabeprazole sodium | 229 | 10.5K | £964 | +344.0% ▲ |
| Fluticasone furoate | 229 | 239 | £1.7K | +18.2% ▲ |
| Clarithromycin | 226 | 4,456 | £924 | -7.9% ▼ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 226 | 235 | £3.3K | +99.3% ▲ |
| Lacosamide | 225 | 4,508 | £526 | +318.7% ▲ |
| Bisacodyl | 224 | 9,960 | £562 | +70.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.